The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin
- Registration Number
- NCT06516939
- Lead Sponsor
- Shanghai Dermatology Hospital
- Brief Summary
The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
- Sensitive skin with a diagnosis of persistent erythema and a lactate irritation test score of 2-3
- No related skin care products including bovine alkaline fibroblast growth factor were used within 1 month before participating in the experiment, and photoelectric treatment measures were not carried out
- Physical sunscreen should be strict during enrollment
Exclusion Criteria
- Children
- Have serious heart, liver, kidney, and blood system diseases, and severe immunocompromise
- Patients with mental illness or cancer
- Those who have received glucocorticoids, calcineurin inhibitors, topical small molecule drugs, antibiotics or tretinoin within 3 months
- Those who are allergic to basic fibroblast growth factor gel and its components
- Acute dermatitis of the face and perifolliculitis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description The Application of Bovine Basic Fibroblast Growth Factor Gel bFGF - Bovine Basic Gel Bovine Basic Gel -
- Primary Outcome Measures
Name Time Method erythema index 0、1、2、4 week The change rate in lesion clearance of face at 1 month after treatment will be measured as the primary outcome
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Shanghai Skin Disease Hospital
🇨🇳Shanghai, China